Global GABA Receptor Agonist Drug Market Research Report 2023

Report ID: 1976891 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 GABA Receptor Agonist Drug Market Overview
    1.1 Product Overview and Scope of GABA Receptor Agonist Drug
    1.2 GABA Receptor Agonist Drug Segment by Type
        1.2.1 Global GABA Receptor Agonist Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Bamaluzole
        1.2.3 Phenibut
        1.2.4 Baclofen
        1.2.5 Gaboxadol
        1.2.6 Klonopin (clonazepam)
        1.2.7 Tiagbine
    1.3 GABA Receptor Agonist Drug Segment by Application
        1.3.1 Global GABA Receptor Agonist Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
        1.3.3 Psychiatric Disorders and Depression
        1.3.4 Alzheimer
        1.3.5 Epilepsy and Seizure
        1.3.6 Anxiety and Sleep Disorders
        1.3.7 Obesity and Alcoholism
    1.4 Global GABA Receptor Agonist Drug Market Size Estimates and Forecasts
        1.4.1 Global GABA Receptor Agonist Drug Revenue 2017-2028
        1.4.2 Global GABA Receptor Agonist Drug Sales 2017-2028
        1.4.3 GABA Receptor Agonist Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 GABA Receptor Agonist Drug Market Competition by Manufacturers
    2.1 Global GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global GABA Receptor Agonist Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global GABA Receptor Agonist Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers GABA Receptor Agonist Drug Manufacturing Sites, Area Served, Product Type
    2.5 GABA Receptor Agonist Drug Market Competitive Situation and Trends
        2.5.1 GABA Receptor Agonist Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest GABA Receptor Agonist Drug Players Market Share by Revenue
        2.5.3 Global GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GABA Receptor Agonist Drug Retrospective Market Scenario by Region
    3.1 Global GABA Receptor Agonist Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global GABA Receptor Agonist Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America GABA Receptor Agonist Drug Market Facts & Figures by Country
        3.3.1 North America GABA Receptor Agonist Drug Sales by Country
        3.3.2 North America GABA Receptor Agonist Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe GABA Receptor Agonist Drug Market Facts & Figures by Country
        3.4.1 Europe GABA Receptor Agonist Drug Sales by Country
        3.4.2 Europe GABA Receptor Agonist Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific GABA Receptor Agonist Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific GABA Receptor Agonist Drug Sales by Region
        3.5.2 Asia Pacific GABA Receptor Agonist Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America GABA Receptor Agonist Drug Market Facts & Figures by Country
        3.6.1 Latin America GABA Receptor Agonist Drug Sales by Country
        3.6.2 Latin America GABA Receptor Agonist Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa GABA Receptor Agonist Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa GABA Receptor Agonist Drug Sales by Country
        3.7.2 Middle East and Africa GABA Receptor Agonist Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global GABA Receptor Agonist Drug Historic Market Analysis by Type
    4.1 Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
    4.2 Global GABA Receptor Agonist Drug Revenue Market Share by Type (2017-2022)
    4.3 Global GABA Receptor Agonist Drug Price by Type (2017-2022)
5 Global GABA Receptor Agonist Drug Historic Market Analysis by Application
    5.1 Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
    5.2 Global GABA Receptor Agonist Drug Revenue Market Share by Application (2017-2022)
    5.3 Global GABA Receptor Agonist Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Advicenne
        6.1.1 Advicenne Corporation Information
        6.1.2 Advicenne Description and Business Overview
        6.1.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Advicenne GABA Receptor Agonist Drug Product Portfolio
        6.1.5 Advicenne Recent Developments/Updates
    6.2 AstraZeneca
        6.2.1 AstraZeneca Corporation Information
        6.2.2 AstraZeneca Description and Business Overview
        6.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 AstraZeneca GABA Receptor Agonist Drug Product Portfolio
        6.2.5 AstraZeneca Recent Developments/Updates
    6.3 Athena Drug Delivery Solutions
        6.3.1 Athena Drug Delivery Solutions Corporation Information
        6.3.2 Athena Drug Delivery Solutions Description and Business Overview
        6.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product Portfolio
        6.3.5 Athena Drug Delivery Solutions Recent Developments/Updates
    6.4 Biocodex
        6.4.1 Biocodex Corporation Information
        6.4.2 Biocodex Description and Business Overview
        6.4.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Biocodex GABA Receptor Agonist Drug Product Portfolio
        6.4.5 Biocodex Recent Developments/Updates
    6.5 Elan Corporation
        6.5.1 Elan Corporation Corporation Information
        6.5.2 Elan Corporation Description and Business Overview
        6.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Elan Corporation GABA Receptor Agonist Drug Product Portfolio
        6.5.5 Elan Corporation Recent Developments/Updates
    6.6 Eli Lilly and Company
        6.6.1 Eli Lilly and Company Corporation Information
        6.6.2 Eli Lilly and Company Description and Business Overview
        6.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Eli Lilly and Company GABA Receptor Agonist Drug Product Portfolio
        6.6.5 Eli Lilly and Company Recent Developments/Updates
    6.7 H.LundBeck, Merck and Co
        6.6.1 H.LundBeck, Merck and Co Corporation Information
        6.6.2 H.LundBeck, Merck and Co Description and Business Overview
        6.6.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product Portfolio
        6.7.5 H.LundBeck, Merck and Co Recent Developments/Updates
    6.8 GlaxoSmithKline
        6.8.1 GlaxoSmithKline Corporation Information
        6.8.2 GlaxoSmithKline Description and Business Overview
        6.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 GlaxoSmithKline GABA Receptor Agonist Drug Product Portfolio
        6.8.5 GlaxoSmithKline Recent Developments/Updates
    6.9 NovaDel Pharma
        6.9.1 NovaDel Pharma Corporation Information
        6.9.2 NovaDel Pharma Description and Business Overview
        6.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 NovaDel Pharma GABA Receptor Agonist Drug Product Portfolio
        6.9.5 NovaDel Pharma Recent Developments/Updates
    6.10 Novartis
        6.10.1 Novartis Corporation Information
        6.10.2 Novartis Description and Business Overview
        6.10.3 Novartis GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Novartis GABA Receptor Agonist Drug Product Portfolio
        6.10.5 Novartis Recent Developments/Updates
    6.11 OVATION Pharmaceuticals
        6.11.1 OVATION Pharmaceuticals Corporation Information
        6.11.2 OVATION Pharmaceuticals GABA Receptor Agonist Drug Description and Business Overview
        6.11.3 OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 OVATION Pharmaceuticals GABA Receptor Agonist Drug Product Portfolio
        6.11.5 OVATION Pharmaceuticals Recent Developments/Updates
    6.12 Osmotica Pharmaceutical
        6.12.1 Osmotica Pharmaceutical Corporation Information
        6.12.2 Osmotica Pharmaceutical GABA Receptor Agonist Drug Description and Business Overview
        6.12.3 Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Osmotica Pharmaceutical GABA Receptor Agonist Drug Product Portfolio
        6.12.5 Osmotica Pharmaceutical Recent Developments/Updates
    6.13 Pfizer
        6.13.1 Pfizer Corporation Information
        6.13.2 Pfizer GABA Receptor Agonist Drug Description and Business Overview
        6.13.3 Pfizer GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Pfizer GABA Receptor Agonist Drug Product Portfolio
        6.13.5 Pfizer Recent Developments/Updates
    6.14 sanofi-aventis
        6.14.1 sanofi-aventis Corporation Information
        6.14.2 sanofi-aventis GABA Receptor Agonist Drug Description and Business Overview
        6.14.3 sanofi-aventis GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 sanofi-aventis GABA Receptor Agonist Drug Product Portfolio
        6.14.5 sanofi-aventis Recent Developments/Updates
    6.15 VIVUS
        6.15.1 VIVUS Corporation Information
        6.15.2 VIVUS GABA Receptor Agonist Drug Description and Business Overview
        6.15.3 VIVUS GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 VIVUS GABA Receptor Agonist Drug Product Portfolio
        6.15.5 VIVUS Recent Developments/Updates
    6.16 XenoPort
        6.16.1 XenoPort Corporation Information
        6.16.2 XenoPort GABA Receptor Agonist Drug Description and Business Overview
        6.16.3 XenoPort GABA Receptor Agonist Drug Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 XenoPort GABA Receptor Agonist Drug Product Portfolio
        6.16.5 XenoPort Recent Developments/Updates
7 GABA Receptor Agonist Drug Manufacturing Cost Analysis
    7.1 GABA Receptor Agonist Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of GABA Receptor Agonist Drug
    7.4 GABA Receptor Agonist Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 GABA Receptor Agonist Drug Distributors List
    8.3 GABA Receptor Agonist Drug Customers
9 GABA Receptor Agonist Drug Market Dynamics
    9.1 GABA Receptor Agonist Drug Industry Trends
    9.2 GABA Receptor Agonist Drug Market Drivers
    9.3 GABA Receptor Agonist Drug Market Challenges
    9.4 GABA Receptor Agonist Drug Market Restraints
10 Global Market Forecast
    10.1 GABA Receptor Agonist Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of GABA Receptor Agonist Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of GABA Receptor Agonist Drug by Type (2023-2028)
    10.2 GABA Receptor Agonist Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of GABA Receptor Agonist Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of GABA Receptor Agonist Drug by Application (2023-2028)
    10.3 GABA Receptor Agonist Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of GABA Receptor Agonist Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of GABA Receptor Agonist Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global GABA Receptor Agonist Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global GABA Receptor Agonist Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global GABA Receptor Agonist Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global GABA Receptor Agonist Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global GABA Receptor Agonist Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global GABA Receptor Agonist Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global GABA Receptor Agonist Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global GABA Receptor Agonist Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market GABA Receptor Agonist Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers GABA Receptor Agonist Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers GABA Receptor Agonist Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global GABA Receptor Agonist Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA Receptor Agonist Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global GABA Receptor Agonist Drug Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)
    Table 17. Global GABA Receptor Agonist Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
    Table 21. North America GABA Receptor Agonist Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe GABA Receptor Agonist Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific GABA Receptor Agonist Drug Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific GABA Receptor Agonist Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific GABA Receptor Agonist Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America GABA Receptor Agonist Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa GABA Receptor Agonist Drug Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa GABA Receptor Agonist Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa GABA Receptor Agonist Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa GABA Receptor Agonist Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global GABA Receptor Agonist Drug Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global GABA Receptor Agonist Drug Sales Market Share by Type (2017-2022)
    Table 41. Global GABA Receptor Agonist Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global GABA Receptor Agonist Drug Revenue Share by Type (2017-2022)
    Table 43. Global GABA Receptor Agonist Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global GABA Receptor Agonist Drug Sales (K Pcs) by Application (2017-2022)
    Table 45. Global GABA Receptor Agonist Drug Sales Market Share by Application (2017-2022)
    Table 46. Global GABA Receptor Agonist Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global GABA Receptor Agonist Drug Revenue Share by Application (2017-2022)
    Table 48. Global GABA Receptor Agonist Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Advicenne Corporation Information
    Table 50. Advicenne Description and Business Overview
    Table 51. Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Advicenne GABA Receptor Agonist Drug Product
    Table 53. Advicenne Recent Developments/Updates
    Table 54. AstraZeneca Corporation Information
    Table 55. AstraZeneca Description and Business Overview
    Table 56. AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. AstraZeneca GABA Receptor Agonist Drug Product
    Table 58. AstraZeneca Recent Developments/Updates
    Table 59. Athena Drug Delivery Solutions Corporation Information
    Table 60. Athena Drug Delivery Solutions Description and Business Overview
    Table 61. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Athena Drug Delivery Solutions GABA Receptor Agonist Drug Product
    Table 63. Athena Drug Delivery Solutions Recent Developments/Updates
    Table 64. Biocodex Corporation Information
    Table 65. Biocodex Description and Business Overview
    Table 66. Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Biocodex GABA Receptor Agonist Drug Product
    Table 68. Biocodex Recent Developments/Updates
    Table 69. Elan Corporation Corporation Information
    Table 70. Elan Corporation Description and Business Overview
    Table 71. Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Elan Corporation GABA Receptor Agonist Drug Product
    Table 73. Elan Corporation Recent Developments/Updates
    Table 74. Eli Lilly and Company Corporation Information
    Table 75. Eli Lilly and Company Description and Business Overview
    Table 76. Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Eli Lilly and Company GABA Receptor Agonist Drug Product
    Table 78. Eli Lilly and Company Recent Developments/Updates
    Table 79. H.LundBeck, Merck and Co Corporation Information
    Table 80. H.LundBeck, Merck and Co Description and Business Overview
    Table 81. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. H.LundBeck, Merck and Co GABA Receptor Agonist Drug Product
    Table 83. H.LundBeck, Merck and Co Recent Developments/Updates
    Table 84. GlaxoSmithKline Corporation Information
    Table 85. GlaxoSmithKline Description and Business Overview
    Table 86. GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. GlaxoSmithKline GABA Receptor Agonist Drug Product
    Table 88. GlaxoSmithKline Recent Developments/Updates
    Table 89. NovaDel Pharma Corporation Information
    Table 90. NovaDel Pharma Description and Business Overview
    Table 91. NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. NovaDel Pharma GABA Receptor Agonist Drug Product
    Table 93. NovaDel Pharma Recent Developments/Updates
    Table 94. Novartis Corporation Information
    Table 95. Novartis Description and Business Overview
    Table 96. Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Novartis GABA Receptor Agonist Drug Product
    Table 98. Novartis Recent Developments/Updates
    Table 99. OVATION Pharmaceuticals Corporation Information
    Table 100. OVATION Pharmaceuticals Description and Business Overview
    Table 101. OVATION Pharmaceuticals GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 102. OVATION Pharmaceuticals GABA Receptor Agonist Drug Product
    Table 103. OVATION Pharmaceuticals Recent Developments/Updates
    Table 104. Osmotica Pharmaceutical Corporation Information
    Table 105. Osmotica Pharmaceutical Description and Business Overview
    Table 106. Osmotica Pharmaceutical GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 107. Osmotica Pharmaceutical GABA Receptor Agonist Drug Product
    Table 108. Osmotica Pharmaceutical Recent Developments/Updates
    Table 109. Pfizer Corporation Information
    Table 110. Pfizer Description and Business Overview
    Table 111. Pfizer GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 112. Pfizer GABA Receptor Agonist Drug Product
    Table 113. Pfizer Recent Developments/Updates
    Table 114. sanofi-aventis Corporation Information
    Table 115. sanofi-aventis Description and Business Overview
    Table 116. sanofi-aventis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 117. sanofi-aventis GABA Receptor Agonist Drug Product
    Table 118. sanofi-aventis Recent Developments/Updates
    Table 119. VIVUS Corporation Information
    Table 120. VIVUS Description and Business Overview
    Table 121. VIVUS GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 122. VIVUS GABA Receptor Agonist Drug Product
    Table 123. VIVUS Recent Developments/Updates
    Table 124. XenoPort Corporation Information
    Table 125. XenoPort Description and Business Overview
    Table 126. XenoPort GABA Receptor Agonist Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 127. XenoPort GABA Receptor Agonist Drug Product
    Table 128. XenoPort Recent Developments/Updates
    Table 129. Production Base and Market Concentration Rate of Raw Material
    Table 130. Key Suppliers of Raw Materials
    Table 131. GABA Receptor Agonist Drug Distributors List
    Table 132. GABA Receptor Agonist Drug Customers List
    Table 133. GABA Receptor Agonist Drug Market Trends
    Table 134. GABA Receptor Agonist Drug Market Drivers
    Table 135. GABA Receptor Agonist Drug Market Challenges
    Table 136. GABA Receptor Agonist Drug Market Restraints
    Table 137. Global GABA Receptor Agonist Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 138. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Type (2023-2028)
    Table 139. Global GABA Receptor Agonist Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 140. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 141. Global GABA Receptor Agonist Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 142. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Application (2023-2028)
    Table 143. Global GABA Receptor Agonist Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 144. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 145. Global GABA Receptor Agonist Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 146. Global GABA Receptor Agonist Drug Sales Market Share Forecast by Region (2023-2028)
    Table 147. Global GABA Receptor Agonist Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 148. Global GABA Receptor Agonist Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of GABA Receptor Agonist Drug
    Figure 2. Global GABA Receptor Agonist Drug Market Share by Type in 2021 & 2028
    Figure 3. Bamaluzole Product Picture
    Figure 4. Phenibut Product Picture
    Figure 5. Baclofen Product Picture
    Figure 6. Gaboxadol Product Picture
    Figure 7. Klonopin (clonazepam) Product Picture
    Figure 8. Tiagbine Product Picture
    Figure 9. Global GABA Receptor Agonist Drug Market Share by Application in 2021 & 2028
    Figure 10. Attention Deficit Hyperactivity Disorder (ADHD)
    Figure 11. Psychiatric Disorders and Depression
    Figure 12. Alzheimer
    Figure 13. Epilepsy and Seizure
    Figure 14. Anxiety and Sleep Disorders
    Figure 15. Obesity and Alcoholism
    Figure 16. Global GABA Receptor Agonist Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global GABA Receptor Agonist Drug Market Size (2017-2028) & (US$ Million)
    Figure 18. Global GABA Receptor Agonist Drug Sales (2017-2028) & (K Pcs)
    Figure 19. GABA Receptor Agonist Drug Sales Share by Manufacturers in 2021
    Figure 20. Global GABA Receptor Agonist Drug Revenue Share by Manufacturers in 2021
    Figure 21. The Global 5 and 10 Largest GABA Receptor Agonist Drug Players: Market Share by Revenue in 2021
    Figure 22. GABA Receptor Agonist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 23. Global GABA Receptor Agonist Drug Sales Market Share by Region (2017-2022)
    Figure 24. Global GABA Receptor Agonist Drug Sales Market Share by Region in 2021
    Figure 25. Global GABA Receptor Agonist Drug Revenue Market Share by Region (2017-2022)
    Figure 26. Global GABA Receptor Agonist Drug Revenue Market Share by Region in 2021
    Figure 27. U.S. GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Canada GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Germany GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. France GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. U.K. GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Italy GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Russia GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Japan GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. South Korea GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. India GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Australia GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Taiwan GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Indonesia GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Thailand GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Malaysia GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Philippines GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Vietnam GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Mexico GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Brazil GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Argentina GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Turkey GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. Saudi Arabia GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. UAE GABA Receptor Agonist Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 51. Sales Market Share of GABA Receptor Agonist Drug by Type (2017-2022)
    Figure 52. Manufacturing Cost Structure of GABA Receptor Agonist Drug
    Figure 53. Manufacturing Process Analysis of GABA Receptor Agonist Drug
    Figure 54. GABA Receptor Agonist Drug Industrial Chain Analysis
    Figure 55. Channels of Distribution
    Figure 56. Distributors Profiles
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Advicenne
AstraZeneca
Athena Drug Delivery Solutions
Biocodex
Elan Corporation
Eli Lilly and Company
H.LundBeck, Merck and Co
GlaxoSmithKline
NovaDel Pharma
Novartis
OVATION Pharmaceuticals
Osmotica Pharmaceutical
Pfizer
sanofi-aventis
VIVUS
XenoPort
Frequently Asked Questions
GABA Receptor Agonist Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
GABA Receptor Agonist Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
GABA Receptor Agonist Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Radioimmunotherapy

Radioimmunotherapy market is segmented by players, region (country), by Type and by Application.  ... Read More

Proto-Oncogene Drgu

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More